Jason Duncan

Companies

• Neumora Therapeutics, Inc.Officer Feb 18, 2025 to now¹
• Neumora Therapeutics, Inc.General counsel Dec 12, 2023 to Dec 12, 2023²
• ALBIREO PHARMA, INC.General counsel Jun 11, 2018 to Mar 2, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APALBIREO PHARMA, INC.0 shares⁴Mar 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 2, 2023U 3,296 shares of ALBIREO PHARMA, INC.⁴
• Jan 23, 2023Sold 228 shares at $43.80 of ALBIREO PHARMA, INC.⁵
• Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.⁶
• Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.⁷
• Jan 19, 2023Sold 938 shares at $43.90 of ALBIREO PHARMA, INC.⁸
• Oct 24, 2022Sold 456 shares at $19.40 of ALBIREO PHARMA, INC.⁹
• Oct 24, 2022Sold 96 shares at $19.54 of ALBIREO PHARMA, INC.⁹
• Oct 24, 2022Sold 104 shares at $19.58 of ALBIREO PHARMA, INC.⁹
• Jul 25, 2022Sold 220 shares at $23.66 of ALBIREO PHARMA, INC.¹⁰
• Jul 25, 2022Sold 93 shares at $24.40 of ALBIREO PHARMA, INC.¹⁰
• Jul 22, 2022Sold 238 shares at $24.45 of ALBIREO PHARMA, INC.¹⁰
• Jul 22, 2022Sold 106 shares at $24.68 of ALBIREO PHARMA, INC.¹⁰
• Apr 25, 2022Sold 91 shares at $33.40 of ALBIREO PHARMA, INC.¹¹
• Apr 25, 2022Sold 221 shares at $33.44 of ALBIREO PHARMA, INC.¹¹
• Apr 22, 2022Sold 103 shares at $32.93 of ALBIREO PHARMA, INC.¹¹
• Apr 22, 2022Sold 240 shares at $33.07 of ALBIREO PHARMA, INC.¹¹
• Jan 24, 2022Sold 1,176 shares at $24.94 of ALBIREO PHARMA, INC.¹²
• Jan 24, 2022Sold 96 shares at $25.09 of ALBIREO PHARMA, INC.¹²
• Jan 24, 2022Sold 416 shares at $24.88 of ALBIREO PHARMA, INC.¹²
• Jan 18, 2022Granted 10,800 shares of ALBIREO PHARMA, INC.¹³
• Oct 25, 2021Sold 217 shares at $29.21 of ALBIREO PHARMA, INC.¹⁴
• Oct 22, 2021Sold 95 shares at $28.85 of ALBIREO PHARMA, INC.¹⁴